- Exchange: Tokyo
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
Kyowa Hakko Kirin Co Ltd+ Add to Watchlist
4151:JP1,662.0 JPY 23.0 1.36%
As of 02:00:00 ET on 05/22/2015.
Company Profile for Kyowa Hakko Kirin Co Ltd (4151)
Kyowa Hakko Kirin Co.,Ltd. develops, manufactures, and markets pharmaceuticals. The Company's products include a protein produced by genetic recombination technology, an anti-anemia agent that attaches new sugar chains through partial modification of the amino acid sequence of human erythropoietin (EPO), and a glycoprotein, human erythropoietin.
Kyowa Hakko Kirin Co Ltd
Key Executives for Kyowa Hakko Kirin Co Ltd (4151)
|Nobuo HanaiPresident||Hiroyuki KawaiExecutive Vice President|
|Kazuyoshi TachibanaManaging Executive Officer||Toshifumi MikayamaManaging Executive Officer|
|Yoichi SatoManaging Executive Officer|